USPTO serial 79414002
ELYSION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 25, 2026
- Examiner
- AGREDA, SAMANTHA LEIGH
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ELYSION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
OXFORD NANOPORE TECHNOLOGIES PLC
OXFORD, GB
OXFORD NANOPORE TECHNOLOGIES PLC
OXFORD, GB
OXFORD NANOPORE TECHNOLOGIES PLC
OXFORD, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AveBoston, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific research and laboratory apparatus, namely, laboratory robots; sensing devices being electrochemical sensors for determining an analyte, in particular for single molecule sensing or determining a polynucleotide, polypeptide and polysaccharide, all for scientific laboratory use; scientific laboratory research devices for DNA analysis, namely, nanopore sensing devices; analytical apparatus and instruments for scientific, industrial, agricultural or non-medical use, namely, scientific laboratory research instruments for DNA analysis; pipetting devices being laboratory pipettes and sampling devices being capillary tubes for samples for laboratory use, dispensers being disposable reusable dispenser syringes for laboratory use, motorized syringe dilutors for scientific laboratory research use, pumps for syringes being structural parts of disposable reusable dispenser syringes for laboratory use and dosing apparatus for laboratory use, namely, dosage dispensers for measuring and dispensing portions of fluids, powders and solid granules, not for medical use; Laboratory robots for laboratory automation and laboratory robots for the automation of analysis processes; Laboratory robots for automated dispensing of a sample to a sensing device, in particular a nanopore sensing device for single molecule sensing, not for medical use; laboratory apparatus and instruments used for extraction and sample preparation, namely, laboratory robots; microplate readers, namely light absorption measuring apparatus and luminescence and fluorescence measuring apparatus; imaging devices for scientific use, namely non-medical imaging devices for genetic sequences; microplate washers for scientific laboratory research use; disposable pipette tips for laboratory use; disposable containers for reagents and samples in connection with pipetting devices, namely, capillary tubes for samples for laboratory use; Microplates for scientific laboratory research use; cell counting chambers for scientific use, namely, flow cytometers and flow-based analyzers providing cell counting for scientific use and not for medical use; extraction plates being solid phase extraction cartridges for laboratory use; extraction columns being laboratory extraction columns for use in genomic sequencing and not for medical use; syringes for dilutors being disposable reusable dispenser syringes for laboratory use; valves for dilutors being structural parts of disposable reusable dispenser syringes for laboratory use; Downloadable software for controlling laboratory apparatus and for controlling medical apparatus; Downloadable software for evaluation of measurement results; Downloadable software for controlling a robot for laboratory sample preparation; Downloadable software for automated delivery of a sample to a sensing device for sensing; Downloadable software for image analysis; Downloadable software for use in remote monitoring of laboratory apparatus; Downloadable software for remote maintenance of laboratory apparatus; Downloadable software for connecting laboratory apparatus to computer networks; Downloadable software for use in the automation of laboratories; Downloadable training software for accessing training in the field of laboratory apparatus automation; downloadable electronic information being electronic data files featuring DNA analysis and genomic sequences and downloadable electronic publications in the nature of scientific articles, journals, reports, and manuals in the fields of genomics, DNA and RNA sequencing, molecular biology, and laboratory automation; recorded electronic data files featuring DNA analysis and genome sequences; downloadable course materials for training and education, namely, downloadable educational course materials in the fields of genomics, DNA and RNA sequencing, molecular biology, and laboratory automation | ACTIVE | — |
| 042 | Scientific research for chemical, biochemical, industrial, agricultural, biological, bacteriological, medical or veterinary purposes; Scientific research, namely biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis services for scientific research purposes; industrial analysis and research services relating to robots for laboratory automation, automation of analysis processes and automated dispensing of a sample to a sensing device; industrial analysis and research services relating to an integrated apparatus comprising a robot for automated sample preparation and dispensing and a sensing device, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; scientific research for medical or veterinary purposes; Scientific laboratory services, namely, protein sequencing services; design and development of laboratory instruments and apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; laboratory testing services, namely, laboratory testing of materials; DNA and polynucleic acid testing services, namely, laboratory testing of DNA and polynucleic acid for scientific research purposes; Scientific research, namely, genome sequencing services; scientific and technological services for the analysis and evaluation of data, including scientific and medical data, namely, DNA analysis services for scientific research purposes and scientific analysis of genomes, not for medical purposes; scientific and technological services related to overseeing, monitoring and managing scientific and medical experiments and tests, namely, scientific laboratory services and scientific research; scientific and technological services related to overseeing, monitoring and managing the analysis and evaluation of scientific and medical data, namely, scientific laboratory services and scientific research; design of scientific experiments, namely, scientific research and development; scientific analysis of data generated by scientific and medical experiments and tests for scientific research purposes; scientific research, namely, biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services, being scientific and technological services; scientific research, namely, DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services, being scientific and technological services; scientific research, namely, genome sequencing services and the analysis and evaluation of data resulting therefrom; provision of reports being technical writing relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services; technical data analysis and evaluation services, namely, data mining; electronic data storage services; application service provider (ASP) services featuring computer software applications for conducting scientific research and scientific experiments for use with data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices; scientific research information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES PLC
- Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES PLC
- Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES PLC
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named ELYSION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 25, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 25, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 7, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 7, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 1, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 18, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 10, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 10, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 10, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 1, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 31, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 25, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 25, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 25, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 22, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 17, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 17, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 19, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 19, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 12, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 11, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 10, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 10, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |